Assaying of tumor necrosis factor α, complement factors, and α-1-antitrypsin in the diagnosis of malignant serous effusions

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 6, 2001, Pages 562-565

  Alexandrakis, Michael G ^a   Kyriakou, Despina ^a   Koutroubakis, Ioannis E ^a   Alexandraki, Rea ^b   Vlachonikolis, Ioannis G ^a   Eliopoulos, George D ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Venizelion General Hospital   (Greece)

Author keywords

Ascites; Cytokines; Exudate; Serous effusions; Transudate; Tumor markers

Indexed keywords

ALPHA 1 ANTITRYPSIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASCITES; BLEEDING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; EXUDATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEUM EXUDATE; PLEURA EFFUSION; PREDICTION; SENSITIVITY AND SPECIFICITY;

ALPHA 1-ANTITRYPSIN; ASCITIC FLUID; COMPLEMENT SYSTEM PROTEINS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035209499     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200112000-00006     Document Type: Article

References (14)

1. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease
2. Diagnostic value of soluble interleukin-2 receptors in pleural effusions
3. The serum ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites
4. Pleural effusions: The diagnostic separation of transudates and exudates
5. 4 in pleural effusion differentiation
6. Detection of tumor necrosis factor/cachectin in pleural effusion of patients with lung cancer
7. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions
8. Role of tumor necrosis factoralpha in the differential diagnosis of parapneumonic effusion
9. Complement components and their activation products in pleural fluid
10. Ascitic fluid α1 antitrypsin
11. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis
12. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis
13. Clinical significance of complements in ascitic diseases: Elevated complement levels disapproving the liver disease origin
14. Changes in serum alpha-1-antitrypsin, alpha-1-acid glycoprotein and beta-2-glycoprotein in patients with malignant hepatocellular carcinoma